AbbVie: Plenty Of Positives

After five months of price weakness, AbbVie (NYSE: ABBV ) has seen a strong August, with 11.4% MoM gains so far. As a result, it has risen by 16.6% YTD, a big jump from the just 3.8% YTD increase it had seen when IManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green Growth Giants ...